Impact on Life Expectancy After Bariatric Surgery

2011 ◽  
pp. 359-387
Author(s):  
Luca Busetto ◽  
Elisa Calo' ◽  
Marco Mazza ◽  
Giuliano Enzi
2020 ◽  
Vol 383 (16) ◽  
pp. 1535-1543 ◽  
Author(s):  
Lena M.S. Carlsson ◽  
Kajsa Sjöholm ◽  
Peter Jacobson ◽  
Johanna C. Andersson-Assarsson ◽  
Per-Arne Svensson ◽  
...  

Author(s):  
Andrea Deledda ◽  
Stefano Pintus ◽  
Andrea Loviselli ◽  
Michele Fosci ◽  
Giovanni Fantola ◽  
...  

The obesity epidemic, mainly due to lifestyle changes in recent decades, leads to serious comorbidities that reduce life expectancy. This situation is affecting the health policies of many nations around the world. Traditional measures such as diet, physical activity, and drugs are often not enough to achieve weight loss goals and to maintain the results over time. Bariatric surgery (BS) includes various techniques, which favor rapid and sustained weight loss. BS is a useful and, in most cases, the best treatment in severe and complicated obesity. In addition, it has a greater benefit/risk ratio than non-surgical traditional therapies. BS can allow the obese patient to lose weight quickly compared with traditional lifestyle changes, and with a greater probability of maintaining the results. Moreover, BS promotes improvements in metabolic parameters, even diabetes remission, and in the quality of life. These changes can lead to an increase of life expectancy by over 6 years on average. The nutrition of people before and after BS must be the subject of indications from a trained staff, and patients must be followed in the subsequent years to reduce the risk of malnutrition and the associated problems. In particular, it is still debated whether it is necessary to lose weight prior to surgery, a procedure that can facilitate the surgeon’s work reducing the surgical risk, but at the same time, lengthens preparation times increasing the risks associated with concomitant pathologies. Furthermore, preventing nutritional deficiencies prior to the intervention can improve the results and reduce short- and long-term mortality.


Author(s):  
Epifânio Feitosa da SILVA-NETO ◽  
Cecília Mª Passos VÁZQUEZ ◽  
Fabiana Melo SOARES ◽  
Danielle Góes da SILVA ◽  
Márcia Ferreira Cândido de SOUZA ◽  
...  

Background : The conventional treatment of obesity presents unsatisfactory results on weight loss and its long-term sustainability, therefore bariatric surgery has been suggested as an effective therapy, determining sustainable long-term weight loss, reversal of components of cardiometabolic risk and improved quality and life expectancy. Aim : To investigate the clinical component of the cardiometabolic risk in patients undergoing bariatric surgery assisted on outpatient basis. Methods : The sample consisted of 47 patients with ages between 18 and 60 years, 72% females. Diabetes mellitus, hypertension, and dyslipidemia were prospectively evaluated by using the Assessment of Obesity-Related Co-morbidities scale. Results : Occurred improvement in these co-morbidities within 12 months after surgery. Co-morbidities resolved were greater than those improved. Conclusion : The study revealed that the Assessment of Obesity-Related Co-morbidities is a system that can be effectively used to quantify the degree of reduction of the severity of the cardiometabolic risk in response to bariatric surgery.


2015 ◽  
Vol 261 (5) ◽  
pp. 914-919 ◽  
Author(s):  
Daniel P. Schauer ◽  
David E. Arterburn ◽  
Edward H. Livingston ◽  
Karen J. Coleman ◽  
Steve Sidney ◽  
...  

2008 ◽  
Vol 134 (1) ◽  
pp. 358-359
Author(s):  
Lauren B. Gerson

Sign in / Sign up

Export Citation Format

Share Document